LEX-WK-N7KKK5JCcrawled 2021-11-09 11:33Z
Litigation vs. Licensing: Manufacturers of the Two Most Recently Approved Biosimilars Take Different Approaches to Reference Drug Patents
Benjamin R. Holt · Biosimilars Law Bulletin · Published December 5, 2017
Work details
- author
- Benjamin R. Holt
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Health Care and Life Sciences · Intellectual Property
- published
- 2017-12-05
Citation
Benjamin R. Holt, Litigation vs. Licensing: Manufacturers of the Two Most Recently Approved Biosimilars Take Different Approaches to Reference Drug Patents, Biosimilars Law Bulletin (December 5, 2017) [The Library at LexBlog, LEX-WK-N7KKK5JC, lexpid.org/N7KKK5JC]